The invention is in the field of electrochemical actuation of microfluidic devices, including pumping action, valving action, flow rate control, flow direction control, dispense control, sample introduction, and amplification of volumetric flow rate or pressure and solution storage.
Microfluidic devices have great promise to revolutionize a wide range of detection and fluid delivery applications, including environmental testing, product quality control and clinical diagnostics/drug delivery. Microfluidics can scale down the size, power requirements, reagent use and waste production of assays and can control the delivery of fluids in minute quantities. Furthermore, with the applications described as examples in this patent realized, new uses for microfluidic systems are likely to ensue.
There are many research and product development teams around the world that are studying miniaturized assay platforms and detection technologies. However, the full potential of these technologies will not be realized until entire microfluidic systems are envisioned and engineered. All aspects of a microfluidic device (such as pumps, valves, chambers, amplifiers, fluidic paths and more) must meet the mandates of small footprint, low power requirements and precise/reproducible control.
The inventors hereof have recognized that electrochemical actuators may be key components of microfluidic devices. The use of controlled electrical flow to drive a chemical reaction that then actuates a device component would allow for miniaturization of all device aspects. The coordinated use of these components would allow for actuation and precise control of complicated flow regimes in microfluidic devices. Microfluidic devices could make use of the electrochemical actuators described herein, along with magnetic, magnetohydrodynamic, ultrasonic, electrohydrodynamic, electroosmotic, piezoelectric and electrokinetic actuation mechanisms.
The inventors hereof have recognized that insulin delivery would be an application of great value for the fluid delivery devices described herein according to preferred embodiments of the present invention. The delivery of insulin to diabetic patients in precisely programmed basal/bolus doses may be better than multiple daily injections. The benefits of such controlled delivery include tighter glycemic control with less fluctuation, greater control of nighttime hypoglycemia and post-meal hyperglycemia, lower total insulin requirements, and the ability to precisely track insulin dosage. Patients prefer wearable drug delivery devices due to the more convenient and unobtrusive lifestyle they offer, flexibility in eating schedules, assistance in dose calculation/delivery, and data storage. The inventors have further recognized that when integrated with a glucose sensor, the result of such a system could be an automatic feedback basal/bolus control for proactive prevention of diabetic complications. The resulting “artificial pancreas” system according to a preferred embodiment would be a major revolution in the treatment of diabetes, since it would closely mimic the function of the natural pancreas. Closed loop drug delivery and sensor monitoring, safety from mechanical and non-mechanical failures, and programmed, heuristic insulin delivery are some of the advantages that the inventors foresee using such a device.
Currently, there are many commercial insulin delivery systems available in the marketplace. Each of those systems, however, suffers from certain disadvantages that have prevented widespread adoption of these systems in place of multiple daily insulin injections. Currently available wearable insulin delivery devices are expensive, require frequent replacement, suffer from mechanical failures, or require management of multiple components and complex operations. What is desired then is a delivery device that overcomes the shortcomings of existing commercial devices, specifically seeking to realize low cost, optimal performance, small and ergonomic design, minimal power usage, and multiple level fail-safety, all of which are enabled by the appropriate combination of electrochemically actuated components, as described here.
References and information mentioned in this background section are not admitted to be prior art with respect to the present invention.
The present invention is directed to the coordinated use of electrochemical pumps and valves, which allows for the creation of small, elegant, complex, inexpensive, microfluidic devices with very low power requirements. These devices have the greatest potential to revolutionize medical diagnostics and treatments, in particular for applications in low-resources settings or those that would benefit from rapid diagnosis/application. Furthermore, the control systems for these devices are minimal and require very low voltages, allowing for on-board and/or remote controlled operation. A number of embodiments are detailed herein that show the broad applicability of this invention. These embodiments are not meant in any way to limit the scope of this invention.
In certain aspects, the present invention is directed to a fluid delivery device including at least one electrochemical pump/pumping method and at least one electrochemical valve/valving method that controls movement of a fluid from one location to another. Such fluids may include, without limitation, drug delivery fluids. For example, the invention could be used to move a liquid from an external reservoir into an application such as delivering a drug to a patient. Two of the many applications for the present invention include the delivery of insulin to diabetic patients and delivery of medicines to the eyes of humans or animals. The elimination of the need for mechanical pumps and valves reduces the overall size, complexity, and power consumption of the device, which allows for miniaturization of the whole device to the desired extent. In certain embodiments, the device may also act as a closed valve when not in use, preventing fluid from inadvertently passing from the reservoir to the application. In this manner, certain embodiments of the present invention provide a failsafe mechanism for preventing accidental drug delivery. The invention in certain embodiments may allow for very fine-tuned control of fluid delivery in either continuous or bolus doses. Using insulin as an example, the device could be used to very closely mimic natural insulin delivery rates from a healthy pancreas.
In a first aspect, the invention is directed to a device for the directional delivery of a fluid, comprising a pump module comprising an electrochemical actuator configured to selectively apply a pressure within the pump module, an inlet valve comprising an electrochemical actuator configured to selectively apply a pressure within the inlet valve, an outlet valve comprising an electrochemical actuator configured to selectively apply a pressure within the outlet valve, an external reservoir in fluid communication with the inlet valve, an application in fluid communication with the outlet valve, a first channel fluidically connecting the inlet valve and the pump module, a second channel fluidically connecting the outlet valve and the pump module, an inlet diaphragm positioned within the inlet valve, wherein the inlet diaphragm is flexible to assume one of a flexed state and an unflexed rest state, and wherein the inlet diaphragm is positioned to block flow of the fluid between the external reservoir and the first channel when the diaphragm is in the unflexed rest state, and to allow flow of the fluid between the external reservoir and the first channel when the inlet diaphragm is in the flexed state, an outlet diaphragm positioned within the outlet valve, wherein the outlet diaphragm is flexible to assume one of a flexed state and an unflexed rest state, and wherein the outlet diaphragm is positioned to block flow of the fluid between the second channel and the application when the diaphragm is in the unflexed rest state, and to allow flow of the fluid between the second channel and the application when the diaphragm is in the flexed state, and an internal reservoir diaphragm positioned within the pump module, wherein the internal reservoir diaphragm is flexible to assume one of a flexed state and an unflexed rest state, and wherein the internal reservoir diaphragm is positioned to receive flow of the liquid from the first channel into a reservoir formed by the internal reservoir diaphragm when the internal reservoir diaphragm is in the flexed state, and to discharge the fluid from the reservoir into the second channel when the internal reservoir diaphragm moves from the flexed state to the unflexed state.
In a second aspect, the invention is directed to a method of directionally pumping a fluid using a pump, wherein the pump comprises a pump module, an inlet valve, an outlet valve, an external reservoir inlet in fluid communication with the inlet valve, an application outlet in fluid communication with the outlet valve, an inlet channel fluidically connecting the inlet valve and the pump module, an outlet channel fluidically connecting the outlet valve and the pump module, an inlet diaphragm positioned within the inlet valve, an outlet diaphragm positioned within the outlet valve, and an internal reservoir diaphragm positioned within the pump module, the method comprising the steps of activating the inlet valve to create a force in a first direction, whereby the inlet diaphragm flexes in the first direction to form an inlet passage between the external reservoir inlet and the inlet channel, activating the pump module to create a force in the first direction, whereby the internal reservoir diaphragm flexes in the first direction to form an internal reservoir, and thereby drawing the fluid from the external reservoir inlet into the internal reservoir, activating the inlet valve to create a force in a second direction, whereby the inlet diaphragm returns to a rest state to close the inlet passage between the external reservoir inlet and the inlet channel, activating the outlet valve to create a force in the second direction, whereby the outlet diaphragm flexes in the second direction to form an outlet passage between the outlet channel and the application outlet, and activating the pump module to create a force in the second direction, whereby the internal reservoir diaphragm flexes in the second direction, thereby forcing fluid from the internal reservoir through the outlet channel and into the application outlet.
In a third aspect, the invention is directed to a method of directionally pumping a fluid using a pump, wherein the pump comprises a pump module, an inlet valve, an outlet valve, a first external reservoir inlet and a second external reservoir inlet in fluid communication with the inlet valve, a first application outlet and a second application outlet in fluid communication with the outlet valve, a first inlet channel and a second inlet channel fluidically connecting the inlet valve and the pump module, a first outlet channel and a second outlet channel fluidically connecting the outlet valve and the pump module, a first inlet diaphragm and a second inlet diaphragm positioned within the inlet valve, a first outlet diaphragm and a second outlet diaphragm positioned within the outlet valve, and a first internal reservoir diaphragm and a second internal reservoir diaphragm positioned within the pump module, the method comprising the steps of activating the inlet valve to create a force in a first direction, whereby the first inlet diaphragm flexes in the first direction to form a first inlet passage between the first external reservoir inlet and the first inlet channel, and the second inlet diaphragm flexes in the first direction to close a second inlet passage between the second external reservoir inlet and the second inlet channel, activating the pump module to create a force in the first direction, whereby the first internal reservoir diaphragm flexes in the first direction to form a first internal reservoir, and thereby drawing the fluid from the first external reservoir inlet into the first internal reservoir, activating the inlet valve to create a force in a second direction, whereby the first inlet diaphragm returns to a rest state to close the inlet passage between the first external reservoir inlet and the first inlet channel, and whereby the second inlet diaphragm flexes in the second direction to form a second inlet passage between the second external reservoir inlet and the second inlet channel, activating the outlet valve to create a force in the first direction, whereby the first outlet diaphragm flexes in the first direction to form a first outlet passage between the first outlet channel and the first application outlet, activating the pump module to create a force in a second direction, whereby the first internal reservoir diaphragm flexes in the second direction, thereby forcing fluid from the first internal reservoir through the first outlet channel and into the first application outlet, and whereby the second internal reservoir diaphragm flexes in the second direction, thereby drawing fluid from the second inlet channel into the second internal reservoir, activating the inlet valve to create a force in the first direction, whereby the first inlet diaphragm flexes in the first direction to open the first inlet passage between the first external reservoir inlet and the first inlet channel, and the second inlet diaphragm flexes in the first direction to close the second inlet passage between the second external reservoir inlet and the second inlet channel, activating the outlet valve to create a force in the second direction, whereby the first inlet valve diaphragm flexes in the second direction to close the first outlet passage between the first outlet channel and the first application outlet, and the second outlet diaphragm flexes in the second direction to open the second outlet passage between the second outlet channel and the second application outlet, and activating the pump module to create a force in the first direction, whereby the first internal reservoir diaphragm flexes in the first direction to open the first internal reservoir, and thereby drawing the fluid from the first external reservoir inlet into the first internal reservoir, and whereby the second internal reservoir diaphragm flexes in the first direction, thereby forcing fluid from the second internal reservoir through the second outlet channel and into the second application outlet.
In a fourth aspect, the invention is directed to an electrochemical actuator, comprising a semi-permeable membrane comprising a first and second side, a first pump body positioned adjacent to the first membrane side, a second pump body positioned adjacent to the second membrane side, a first diaphragm positioned adjacent to the first pump body opposite from the semi-permeable membrane, a second diaphragm positioned adjacent to the second pump body opposite from the semi-permeable membrane, a first pump cap positioned adjacent to the first diaphragm, and a second pump cap positioned adjacent to the second diaphragm.
In a fifth aspect, the invention is directed to a valve actuator in communication with a fluidic path, comprising an electrochemical pump comprising an elastomer, a mechanical valve in contact with the elastomer, whereby the mechanical valve is operable to open and close the fluidic path, and a force generator configured to generate a force capable of moving the mechanical valve against the elastomer in a direction opposite of a direction in which the elastomer expands as a result of operation of the electrochemical pump.
In a sixth aspect, the invention is directed to a fluid control mechanism, comprising a flexible fluid container comprising a volume, and an electrochemical actuator comprising an elastomer diaphragm, wherein the electrochemical actuator is configured to flex the elastomer diaphragm outward, and further wherein the elastomer diaphragm is in contact with the fluid container whereby outward flexing of the elastomer diaphragm reduces the volume of the fluid container.
In a seventh aspect, the invention is directed to an actuation device, comprising an electrochemical actuator comprising an elastomer diaphragm, wherein the electrochemical actuator is configured to flex the elastomer diaphragm outward and wherein the electrochemical actuator comprises a diaphragm cross-sectional area, a piston comprising a first and second section wherein the piston first section is connected to the elastomer diaphragm, and a flow channel sized to receive the second section of the piston.
In an eighth aspect, the invention is directed to a galvanic electrochemical actuator, comprising a first electrochemical cell half comprising an electrolyte and a cathode/anode, a second electrochemical cell half comprising the electrolyte and an anode/cathode, an ion-permeable membrane separating the first and second electrochemical cell halves, and an electrical connection between the cathode and anode, whereby an ion flux is generated through the ion permeable membrane.
The inventors have recognized numerous additional applications, including a single-dose fluid delivery device, a continuous-dose fluid delivery device, disposable, low-cost actuators, self-powered actuators, magnetic valve actuators, elastic valve actuators, programmable microfluidic chips, flow rate and fluid force amplification actuators and self-contained ELISA chips.
The inventors have further recognized that the small size, low power requirements and non-mechanical nature of electrochemical actuators according to various embodiments means that devices composed of these actuators could be small and complex and provide multiple layers of fail-safety. This safety feature would be particularly important if the fluid being delivered is a drug to a patient and would greatly reduce the possibility of overdose. Additionally, the inventors have recognized that devices based on electrochemical pumps and valves can operate at the pressures and flow rates required to run a sandwich ELISA. In another example, the inventors have recognized that the minimal power requirements needed to run an electrochemically-actuated device could be provided by conventional, battery or solar (for repeated operation) or by an additional chemical reaction (for one-time operation).
These and other objects, features, and advantages of the present invention will become better understood from a consideration of the following detailed description of the preferred embodiments and appended claims in conjunction with the drawings as described following.
Before the present invention is described in further detail, it should be understood that the invention is not limited to the particular embodiments described, and that the terms used in describing the particular embodiments are for the purpose of describing those particular embodiments only, and are not intended to be limiting, since the scope of the present invention will be limited only by the claims. Certain preferred embodiments applicable to particular applications will first be presented below in overview, and then in a more detailed description in conjunction with the drawings presented herein.
For some applications, it may be desirable to customize attributes of the electrochemical actuator for disposability. Disposable actuators would need to be made of inexpensive materials and be amenable to high-throughput manufacture. The inventors have made key steps in realizing disposability of electrochemical actuators, including snap-together, molded pump bodies; lower cost actuation electrodes (such as titanium), alternative pumping fluids and single-use, self-powered cells.
Electrochemical actuation can be used in concert with magnetic force to repeatedly open or close a fluidic path as presented in certain preferred embodiments. The fluid force of an electrochemical actuator can be used to push a metal rod into a fluidic path such that the path is blocked to flow of fluid. Then once it is desirable to initiate flow the electrochemically actuated fluid force can be reversed and a force (such as magnetic or vacuum) used to pull the metal rod back out of the fluidic path.
The fluid force of an electrochemical actuator can be used to repeatedly close a fluidic path in certain preferred embodiments by pressing upon an elastic membrane that bulges to block the path. By reversing the direction of the fluid force, the elastic membrane will contract away from the fluidic path to allow for flow. Electrochemically actuated fluid force pressing against a membrane can also be used to push fluid from a filled reservoir or to draw fluid into an empty reservoir. Additionally, electrochemical actuation can be used to drive a piston that is used to amplify the volume or pressure of fluid delivered.
Certain preferred embodiments encompass a wide array of programmable microfluidic chips such that all (or some) of the aspects of fluid movement are controlled by electrochemical actuation. In certain preferred embodiments, a bank of electrochemically actuated elastic valves is positioned along one or both sides of a fluidic channel, and sequential activation is used to move fluid peristaltically along a programmed path. One complicated embodiment for the coordinated use of a number of electrochemical actuators would be a single use, disposable chip for a sandwich ELISA. Key enabling features of a disposable ELISA chip would be on-board positive and negative controls for each test, disposal after one use of all components that come in contact with the sample, and snap fit into electrochemically actuated pump engines and electronic controls/readout.
Turning now to a more specific discussion of the various applications in connection with preferred embodiments of the present invention, an electrochemically-actuated fluid delivery device incorporates electrochemical valves and electrochemical pumps within the same device.
The device of
Referring now to
When at rest as shown in
Referring now to
In the next step shown in
In the next step, shown in
In the next step shown in
In the next step shown in
In the final step shown in
Referring now to
When at rest as shown in
In the first step shown in
In the next step shown in
In the next step shown in
It may be seen that be repeating the steps illustrated at
The preferred embodiments of the fluid delivery devices as described herein provides a number of advantages to traditional pump/valve arrangements used for these applications. Fundamental engineering constraints limit the extent to which mechanical pumps can be miniaturized in order to meet the demands of certain applications, such as a wearable pump used for insulin delivery. In sharp contrast, the directional flow device described here is shape-independent, and requires very little power (typically on the order of mW) to deliver specific flow rates in the pL/min to μL/min flow rate range. More specifically, the device is operable for flow rates in the range of about 1 pL/min to about 100 μL/min, and to operate at a voltage of less than +/−2V. Flow precision is ±5% and dispense volumes as small as 100 nL have been delivered using this technology. Pumping pressures of up to about 300 psi may be achieved. The device according to preferred embodiments also offers truly pulse-free flow that is not normally possible with other pumps when continuous flow is desired. However, pulsed flow, as with bolus delivery of a single-dose of fluid, is also possible using electrochemical-actuation. The electrochemical fluidic action of the device allows it to open and close fluidic channels, acting as a valve as well as providing fluid flow, so that no mechanical valves or other external valving are required for operation.
The advantages of devices according to the preferred embodiment include the expansion of the variety of drugs that can be delivered via a wearable, patched or quasi-implantable device; being refillable during a simple outpatient or patient-administered procedure which is significantly less painful than injecting a new insert. Long-term, steady-state drug levels may lead to improved clinical outcomes; improved compliance and comfort for patients; and reduced number of visits to the physician, and hence reduced costs associated with the use of the device.
In a preferred embodiment, the device is formed from a non-reactive material such as polyetheretherketone (PEEK) plastic and assembled using standard fasteners. Other materials in alternative embodiments may be used, such as various plastic materials, including homo- or copolymers or their blends comprising, in addition to PEEK, polytetrafluoroethylene, polyethylene, polypropylene, polyesters, acrylic polymers, polyetherimide, polyamide, polyimide, and polyacetals. The device may be formed of parts that are, for example, machined or injection molded. The device may also in alternative embodiments be formed of one or more parts that comprise a coating of one material onto a different material, such as, for example, a Teflon coating over steel. In a preferred embodiment, a 2 μL target stroke volume of the device requires only 60 μL of pump fluid in each of the three chambers, limiting the overall size of the device to 180 μL, or 0.180 cm3. The low maximum flow rate of 2 μL/min requires the exposed area of ion selective membrane between any two chambers to be about 0.1 cm2.
Various pumping protocols may be employed with the device according to a preferred embodiment. These will include giving small doses a couple of times a day, dispensing a larger bolus at desired intervals, continuous delivery, or programmable (staged and ramping rate) delivery. These can be adapted to fit each application. The voltage protocols may be optimized to customize the accuracy of dose delivery.
The control system (not shown in the figures) may consist of a battery along with all the hardware and firmware necessary for stand-alone control of the device, as will be readily understood by those skilled in the art. This controller may be connected to a computer, which will upload the specific pumping instructions into the controller's firmware. Then the controller may be removed from the computer and attached to the device, which will then begin the dispensing protocol. Alternatively, the controller can be operated wirelessly from a stationary controller or an enabled wireless communication device, such as a smartphone. The control system is preferably designed to be as small and light as feasible while still providing the voltage control and current necessary to drive the device. The controller also is preferably designed to minimize power requirements to increase battery life. An inductive recharging system may be used as an alternative. In the envisioned final commercial device, this controller may ultimately be hermetically sealed within the body of the device for reliable operation.
In the particular application of insulin delivery, it may be seen that the preferred embodiments described herein offer numerous advantages over existing devices for this purpose. Table 1 summarizes the differences between the device and certain commercially available insulin delivery devices, and also sets forth the advantages that the device offers over these existing commercial devices.
There are several methods to enable disposability of electrochemical actuators, including a molded actuator body, use of less expensive (as compared to platinum) electrodes and self-powered battery-free operation. Example preferred embodiments of each of these attributes is provided herein.
Traditionally, electrochemical actuation has been conducted using a high end electrode material, such as platinum. However, the inventors have found that lower cost materials, such as titanium and palladium, can also be used as electrodes in electrochemical actuators according to a preferred embodiment.
Electrochemical actuation can be driven by a galvanic chemical reaction in which a potential difference is created between the halves of the actuator body upon creation of an electrical connection between the cathode in one half of the cell with the anode in the other half of the cell. An ion flux is generated across the membrane that separates the two halves of the actuator body; this ion flux will continue until either the anode or its corresponding electrolyte is exhausted. Thus, the reaction is in only one direction and is irreversible. The ion flux drives fluid flow within the actuator.
The fluid pumped by an electrochemical actuator can be used to engage or disengage a magnetic valve, as shown in
Another mechanism by which an electrochemical actuator can be used for microfluidic flow control involves direct contact of an elastic diaphragm on an actuator with an elastic diaphragm within a microfluidic network. Because fluid flow within the actuator can be easily and repeatedly reversed, the actuator can be used multiple times to perform the same function. In this embodiment, flow is run in one direction to actuate the device; then the (voltage/current) is reversed, and the resultant flow is reversed to reset the device. The elastic diaphragm on the actuator can be in contact with another elastic diaphragm on a reservoir for dispense/aspirate functions or on a channel itself for pinch valve/pump applications.
This same concept can be used to engineer precise flow control (both pulsed and pulseless) within a microfluidic network. A bank of diaphragm actuators along a fluidic path could be used to open one segment of a path to allow fluid in. The next segment of the path can be opened (partially or fully) while the first segment is being closed (partially or fully). In this manner, fluid could be moved along preprogrammed paths peristaltically. The preprogrammed path could be multidirectional and branching to meet any number of specifications for flow control.
Electrochemical actuation can be used to drive a piston that is used to either increase the volumetric flow rate of fluid or increase the pressure at which fluid is delivered. In
In
In order to return the actuator, piston and reservoir membrane to their original positions, electrochemical actuation would be operated in the opposite direction by supplying current/voltage in the opposite direction. The actuator is then ready to perform another amplification stroke. As shown previously in
In addition to varying the surface area of the pistons, the relative viscosity of the fluid on either side of the piston could be adjusted to customize flow and operation. For example, if a highly viscous fluid were used as the working fluid in the pump, leakage and evaporation from around the piston will be reduced.
Certain ranges have been provided in the description of these particular embodiments with respect to certain parameters. When a range of values is provided, it should be understood that each intervening value between the upper and lower limit of that range and any other stated or intervening value in that stated range is encompassed within the invention, subject to any specifically excluded limit in the stated range. Where the stated range of values includes one or both of the limits, ranges excluding either or both of those limits are also included in the scope of the invention.
Unless otherwise stated, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present invention, a limited number of the exemplary methods and materials are described herein. It will be apparent to those skilled in the art that many more modifications are possible without departing from the inventive concepts herein. All terms used herein should be interpreted in the broadest possible manner consistent with the context. In particular, the terms “comprises” and “comprising” should be interpreted as referring to elements, components, or steps in a non-exclusive manner, indicating that the referenced elements, components, or steps may be present, or utilized, or combined with other elements, components, or steps that are not expressly referenced. As used herein, “consisting of” excludes any element, step, or ingredients not specified in the claim element. As used herein, “consisting essentially of” does not exclude materials or steps that do not materially affect the underlying novel characteristics of the claim. When a Markush group or other grouping is used herein, all individual members of the group and all combinations and subcombinations possible of the group are intended to be individually included in the disclosure. All references cited herein are hereby incorporated by reference to the extent that there is no inconsistency with the disclosure of this specification.
The present invention has been described with reference to certain preferred and alternative embodiments that are intended to be exemplary only and not limiting to the full scope of the present invention as set forth in the appended claims.
This application claims priority from U.S. provisional patent application Ser. No. 61/529,578, filed on Aug. 31, 2011, and entitled “Self-Valving Electrochemical Pump.” Such application is incorporated herein by reference.
This invention was made with Government support under the terms of Grant No. 0848253, awarded by the National Science Foundation and under the terms of Contract No. W81XWH-09-1-0523, awarded by the Department of Defense. The Government has certain rights to the invention.
Number | Date | Country | |
---|---|---|---|
61529578 | Aug 2011 | US |